Millendo Therapeutics acquires Alize Pharma in stock-based transaction Merger beefs up Millendo's congenital adrenal hyperplasia program Alize Pharma is known for developing treatment for Prader-Willi syndrome Millendo Therapeutics Inc. has acquired Alizé Pharma SAS in a stock-based transaction, the Ann Arbor-based biopharmaceutical company announced Wednesday. The deal includes Alizé Pharma's facilities, operations and staff, which will handle research and development. Alize

• Indigo to provide Grain Craft with wheat that is sustainably produced, identity preserved, and meets enhanced milling quality standards Boston, Massachusetts, December 12, 2017 – Grain Craft, the largest independent flour milling company in the United States, has partnered with Indigo Ag, Inc., a company dedicated to harnessing nature to help farmers sustainably feed the planet, in a supply agreement for one million bushels of high quality, sustainably produced, and iden

Preclinical Data Shows Potential of eFT226 in B-cell Malignancies Data to be presented at the ASH 59th Annual Meeting and Exposition SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced that data presented in a poster session at the American Society of Hematology (ASH) 59th Meeting and Annual Exhibition demonstrate clinical activity, includi

SAN FRANCISCO (Reuters) - Farming technology startup Indigo has raised more than $200 million from investors to fund its efforts to reform how crops including wheat, soybeans, cotton and corn are grown around the world. The Boston-based company announced on Wednesday an additional $47 million investment led by the Investment Corporation of Dubai, a state-owned sovereign wealth fund, bringing its latest financing round to $203 million. Indigo is valued after the latest round a